Satellos Bioscience
Toronto
About Satellos Bioscience
Satellos Bioscience is a private regenerative medicine company developing novel therapeutics that stimulate or restore muscle regeneration. The company's programs focus on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Total funding: $97.7M
- Funding stage: M&A
- Last round: Post-IPO Equity (Sep 2025)
- Ticker: tsx:MSCL
- Website: satellos.com
- Phone: 905-336-6128
Industries & Categories
Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/satellos-bioscience-59378 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.